Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT00026442. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Trial Of Two Different Doses Of Capecitabine (XELODA) In Patients With Advanced And/Or Metastatic Breast Cancer
Study identification
- NCT ID
- NCT00026442
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pharmatech Oncology
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- capecitabine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2001
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Dec 17, 2013
Started 2001
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Antelope Valley Hospital | Lancaster | California | 93534 | — |
| Medical Oncology Care Associates | Orange | California | 92868 | — |
| California Cancer Medical Center | West Covina | California | 91790 | — |
| Oncology Clinic, P.C. | Colorado Springs | Colorado | 80907 | — |
| Hematology Oncology Associates of theTreasure Coast - Port St. Lucie | Port Saint Lucie | Florida | 34952 | — |
| North Florida Cancer Center | Saint Augustine | Florida | 32086 | — |
| Maryland Hematology/Oncology Associates | Baltimore | Maryland | 21236 | — |
| Charleston Hematology-Oncology, P.A. | Charleston | South Carolina | 29403 | — |
| Family Cancer Center | Collierville | Tennessee | 38017 | — |
| Logan Regional Hospital | Logan | Utah | 84341 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00026442, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2013 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00026442 live on ClinicalTrials.gov.